CorMedix (CRMD) Net Cash Flow (2010 - 2025)

CorMedix has disclosed Net Cash Flow across 15 years of filings, most recently posting $96.3 million for Q4 2025.

• Net Cash Flow for Q4 2025 came in at $96.3 million, up 1695.31% year-over-year; the trailing twelve-month figure through Dec 2025 was $105.1 million (up 3528.03% YoY), and the FY2025 annual result was $105.1 million, up 3528.03% from the prior year.
• Net Cash Flow came in at $96.3 million for Q4 2025 at CorMedix, up from -$109.9 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $96.3 million in Q4 2025 to a low of -$109.9 million in Q3 2025.
• The 5-year median for Net Cash Flow is -$4.4 million (2021), against an average of $5.2 million.
• Across the five-year window, Net Cash Flow tumbled 8611.45% in 2023 and surged 1695.31% in 2025, its largest moves.
• CorMedix's Net Cash Flow stood at -$13.0 million in 2021, then soared by 99.15% to -$111121.0 in 2022, then sank by 8611.45% to -$9.7 million in 2023, then surged by 155.44% to $5.4 million in 2024, then soared by 1695.31% to $96.3 million in 2025.
• The last three Net Cash Flow figures came in at $96.3 million (Q4 2025), -$109.9 million (Q3 2025), and $93.0 million (Q2 2025), per Business Quant data.